Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Eiger BioPharmaceuticals, Inc. (EIGRQ) had Return on Assets of -193.07% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$15.77M |
|
$-74.96M |
|
$0.02M |
|
$15.75M |
|
$87.56M |
|
$-71.79M |
|
$-3.17M |
|
$-74.96M |
|
$-74.96M |
|
$-74.96M |
|
$-74.96M |
|
$-74.96M |
|
$-74.96M |
|
$-71.79M |
|
$-72.62M |
|
1.48M |
|
1.48M |
|
$-50.78 |
|
$-50.78 |
|
| Balance Sheet Financials | |
$37.84M |
|
$0.63M |
|
$0.99M |
|
$38.83M |
|
$53.28M |
|
-- |
|
-- |
|
$53.28M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
1.48M |
|
| Cash Flow Statement Financials | |
$-74.55M |
|
$74.23M |
|
$0.04M |
|
$25.80M |
|
$25.44M |
|
$-0.36M |
|
$5.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.71 |
|
-- |
|
-- |
|
-- |
|
-2.84 |
|
99.85% |
|
-455.12% |
|
-455.12% |
|
-460.43% |
|
-475.22% |
|
-475.26% |
|
$-74.78M |
|
-- |
|
-- |
|
-- |
|
0.41 |
|
0.02 |
|
9.38 |
|
38.92 |
|
518.49% |
|
518.49% |
|
|
Return on Assets |
-193.07% |
518.49% |
|
$-9.78 |
|
$-50.67 |
|
$-50.51 |
|